Literature DB >> 18499211

Prevention of immunodeficiency virus induced CD4+ T-cell depletion by prior infection with a non-pathogenic virus.

Julie A Terwee1, Jennifer K Carlson, Wendy S Sprague, Kerry S Sondgeroth, Sarah B Shropshire, Jennifer L Troyer, Sue VandeWoude.   

Abstract

Immune dysregulation initiated by a profound loss of CD4+ T-cells is fundamental to HIV-induced pathogenesis. Infection of domestic cats with a non-pathogenic lentivirus prevalent in the puma (puma lentivirus, PLV or FIV(pco)) prevented peripheral blood CD4+ T-cell depletion caused by subsequent virulent FIV infection. Maintenance of this critical population was not associated with a significant decrease in FIV viremia, lending support to the hypothesis that direct viral cytopathic effect is not the primary cause of immunodeficiency. Although this approach was analogous to immunization with a modified live vaccine, correlates of immunity such as a serum-neutralizing antibody or virus-specific T-cell proliferative response were not found in protected animals. Differences in cytokine transcription profile, most notably in interferon gamma, were observed between the protected and unprotected groups. These data provide support for the importance of non-adaptive enhancement of the immune response in the prevention of CD4+ T-cell loss.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499211      PMCID: PMC2490720          DOI: 10.1016/j.virol.2008.03.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  62 in total

1.  Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

Authors:  Miguel Goicoechea; Davey M Smith; Lin Liu; Susanne May; Allan R Tenorio; Caroline C Ignacio; Alan Landay; Richard Haubrich
Journal:  J Infect Dis       Date:  2006-05-18       Impact factor: 5.226

2.  Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239.

Authors:  Jean D Boyer; Paulo C Maciag; Rose Parkinson; Ling Wu; Mark G Lewis; David B Weiner; Yvonne Paterson
Journal:  Vaccine       Date:  2005-08-18       Impact factor: 3.641

3.  Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.

Authors:  Justin R Bailey; Kara G Lassen; Hung-Chih Yang; Thomas C Quinn; Stuart C Ray; Joel N Blankson; Robert F Siliciano
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.

Authors:  Jörn E Schmitz; R Paul Johnson; Harold M McClure; Kelledy H Manson; Michael S Wyand; Marcelo J Kuroda; Michelle A Lifton; Rajinder S Khunkhun; Kimberly J McEvers; Jacqueline Gillis; Michael Piatak; Jeffrey D Lifson; Gudrun Grosschupff; Paul Racz; Klara Tenner-Racz; E Peter Rieber; Kristine Kuus-Reichel; Rebecca S Gelman; Norman L Letvin; David C Montefiori; Ruth M Ruprecht; Ronald C Desrosiers; Keith A Reimann
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase.

Authors:  Mary Poss; Howard A Ross; Sally L Painter; David C Holley; Julie A Terwee; Sue Vandewoude; Allen Rodrigo
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Sustained conservation of CD4+ T cells in multiprotein triple modality-immunized rhesus macaques after intrarectal challenge with simian immunodeficiency virus.

Authors:  Nicole Stolte-Leeb; Ulrike Sauermann; Stephen Norley; Zahra Fagrouch; Jonathan Heeney; Monika Franz; Gerhard Hunsmann; Christiane Stahl-Hennig
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

7.  Role of avidity and breadth of the CD4 T cell response in progression to AIDS.

Authors:  Hester Korthals Altes; Rob de Boer; Maarten Boerlijst
Journal:  Proc Biol Sci       Date:  2006-07-07       Impact factor: 5.349

8.  Feline lentiviruses demonstrate differences in receptor repertoire and envelope structural elements.

Authors:  Natalia Smirnova; Jennifer L Troyer; Jennifer Schissler; Julie Terwee; Mary Poss; Sue VandeWoude
Journal:  Virology       Date:  2005-08-24       Impact factor: 3.616

9.  HIV infection: first battle decides the war.

Authors:  Zdenek Hel; Jerry R McGhee; Jiri Mestecky
Journal:  Trends Immunol       Date:  2006-05-06       Impact factor: 16.687

Review 10.  HIV vaccines.

Authors:  Andrew J McMichael
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

View more
  22 in total

1.  Novel gammaherpesviruses in North American domestic cats, bobcats, and pumas: identification, prevalence, and risk factors.

Authors:  Ryan M Troyer; Julia A Beatty; Kathryn R Stutzman-Rodriguez; Scott Carver; Caitlin C Lozano; Justin S Lee; Michael R Lappin; Seth P D Riley; Laurel E K Serieys; Kenneth A Logan; Linda L Sweanor; Walter M Boyce; T Winston Vickers; Roy McBride; Kevin R Crooks; Jesse S Lewis; Mark W Cunningham; Joel Rovnak; Sandra L Quackenbush; Sue VandeWoude
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

2.  FIV diversity: FIV Ple subtype composition may influence disease outcome in African lions.

Authors:  Jennifer L Troyer; Melody E Roelke; Jillian M Jespersen; Natalie Baggett; Valerie Buckley-Beason; Dan MacNulty; Meggan Craft; Craig Packer; Jill Pecon-Slattery; Stephen J O'Brien
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

3.  Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infection.

Authors:  Wendy S Sprague; Cristian Apetrei; Anne C Avery; Robert L Peskind; Sue Vandewoude
Journal:  Vet Immunol Immunopathol       Date:  2015-07-29       Impact factor: 2.046

4.  Feline Immunodeficiency Virus Cross-Species Transmission: Implications for Emergence of New Lentiviral Infections.

Authors:  Justin Lee; Jennifer L Malmberg; Britta A Wood; Sahaja Hladky; Ryan Troyer; Melody Roelke; Mark Cunningham; Roy McBride; Winston Vickers; Walter Boyce; Erin Boydston; Laurel Serieys; Seth Riley; Kevin Crooks; Sue VandeWoude
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

5.  Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection.

Authors:  Britta A Wood; Scott Carver; Ryan M Troyer; John H Elder; Sue VandeWoude
Journal:  J Immunol Methods       Date:  2013-08-14       Impact factor: 2.303

6.  Microsphere immunoassay for the detection of cytokines in domestic cat (Felis catus) plasma: elevated IL-12/23 in acute feline immunodeficiency virus infections.

Authors:  Britta A Wood; Ryan M Troyer; Julie A Terwee; Sue Vandewoude
Journal:  Vet Immunol Immunopathol       Date:  2012-01-14       Impact factor: 2.046

7.  Temporal association of large granular lymphocytosis, neutropenia, proviral load, and FasL mRNA in cats with acute feline immunodeficiency virus infection.

Authors:  W S Sprague; J A TerWee; S VandeWoude
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

Review 8.  Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV.

Authors:  Sue VandeWoude; Jennifer Troyer; Mary Poss
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

9.  Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.

Authors:  Saipiroon Maksaereekul; Robert A Dubie; Xiaoying Shen; Hung Kieu; Gregg A Dean; Ellen E Sparger
Journal:  Vaccine       Date:  2009-04-17       Impact factor: 3.641

10.  Multivariate statistical analyses demonstrate unique host immune responses to single and dual lentiviral infection.

Authors:  Sunando Roy; Jennie Lavine; Francesca Chiaromonte; Julie Terwee; Sue VandeWoude; Ottar Bjornstad; Mary Poss
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.